IBM

----

2026-W372026-09-07

IBM.US Weekly Report · 2026-W37

Key Highlights

IBM stock posted consecutive gains this week, closing at $243.29, up 3.57% from the previous week’s close. Current valuation sits in the historical low zone (P/E 20.56, only 11.38th percentile over 5 years), coinciding with broad-based inflows and constructive institutional ratings—a three-dimensional bull case on valuation, capital, and analyst consensus. However, the latest quarterly earnings show year-over-year profit decline, warranting close monitoring of recovery potential.

Price Action

Weekly close at $243.29 versus prior close of $234.89 represents a 3.57% gain. Intraweek range spanned $235.00 to $243.63, a 3.7% amplitude relative to opening price. Volume of 4.92 million shares aligned with the 60-day average, indicating gradual rather than explosive buying. The week exhibited low-volume gains punctuated by stronger rallies on individual days (e.g., Sept 9 +3.38%), suggesting measured institutional participation without panic accumulation.

Valuation and Earnings

Current P/E of 20.56x trades at a depressed historical level, sitting in just the 11.38th percentile over the past 5 years—indicating relative undervaluation by historical standards. P/B of 6.65x is less compelling.

Q2 2026 reported EPS of $2.27, down 1.82% year-over-year and weaker than Q1’s $1.28. Operating revenue of $17.16 billion grew only 1.09% year-over-year at anemic pace. Net profit of $2.165 billion declined 1.32% YoY. Overall earnings momentum is subdued.

Consensus forecast (latest snapshot from mid-5-year window) pegs annual EPS at 12.797 with median of 12.789, while trailing-twelve-month EPS stands at 11.384. This implies market participants expect H2 delivery despite Q2’s headwind. If subsequent quarters inflect upward, consensus may prove justified; if not, current valuation floor erodes.

Capital Flows

Capital flows across all segments turned positive:

Large capital (institutional): net inflow of 103.33 units (inflow 522.15 vs. outflow 418.82)
Medium capital: net inflow of 1,067.55 units (inflow 2,819.55 vs. outflow 1,752.00)
Retail: net inflow of 163.22 units (inflow 4,081.81 vs. outflow 3,918.59)

Three-way inflows across all tiers underscore market comfort with current valuation, with mid-tier participation most pronounced. This reflects institutional and mainstream recognition of the low-entry point.

Institutional Ratings

Rating breakdown: 10 Buy, 10 Hold, 1 Neutral, 3 Reduce, 1 Sell (25 firms total). Buy and Hold combined account for 20 of 25 (~80%), indicating mainstream bullish lean. Latest consensus target price stands at $245.35, implying ~0.8% upside from current levels.

Caveat: ratings are backward-looking signals; fresh capital inflows represent the market’s real-time verdict and may be more current than analyst scores.

Weekly News Highlights

AI and quantum computing dominated newsflow. IBM and NASA unveiled a joint AI model for mapping lunar ice and crater formation, demonstrating the company’s foothold in frontier tech. The announcement of a Swiss Quantum Innovation Center with Lockheed Martin underscores validation by large defense-tech peers of IBM’s quantum capabilities.

Separately, collaboration with LTM and Red Hat on “Lightwell,” an AI-driven open-source vulnerability remediation tool, signals progress in AI-native developer solutions. While not yet translated into financials, these initiatives span quantum, cloud-native, and AI—all strategic pillars.

On the investor flows front, multiple asset managers (Bank OZK, Legal & General, Cibc World Market) added or initiated IBM positions, reflecting perceived valuation appeal.

Selected coverage:

Coherence and Contradictions

Valuation, capital, and ratings align in a bullish triad: depressed P/E (11.38th percentile) attracts broad inflows across all investor tiers, while institutional consensus leans constructive (Buy + Hold = 80%). This three-way agreement signals market repricing of IBM’s risk-reward at current levels.

The friction point: latest earnings show YoY profit decline (EPS -1.82%, revenue growth +1.09%), which sits in tension with upbeat ratings. Ratings typically embed older expectations; fresh quarterly results reveal real operating health. If H2 earnings fail to inflect upward, the valuation floor—which fueled recent inflows—risks erosion and capital sentiment may reverse. The outcome hinges on tracking H2 print and management guidance on growth trajectory.